Therapeutic Microvesicles for Extreme Environments

Publication ID: 24-11857582_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Therapeutic Microvesicles for Extreme Environments,” Published Technical Disclosure No. 24-11857582_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857582_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,582.

Summary of the Inventive Concept

This inventive concept adapts therapeutic microvesicles of probiotic bacteria for specific, narrow markets or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions, to promote gut health and immune system function.

Background and Problem Solved

The original patent disclosed therapeutic microvesicles of probiotic bacteria for general health benefits. However, these microvesicles may not be suitable for extreme environments, where temperature, humidity, and oxygen levels can be challenging. This inventive concept addresses these limitations by engineering microvesicles to thrive in high-temperature, high-security, disaster relief, or extreme weather environments.

Detailed Description of the Inventive Concept

The inventive concept comprises therapeutic microvesicles of probiotic bacteria adapted to survive and thrive in extreme environments. These microvesicles can be formulated to withstand high temperatures, low oxygen levels, and limited access to refrigeration. The system, method, composition, kit, and therapeutic microvesicle disclosed in the new claims are designed to promote gut health and immune system function in individuals operating in or affected by extreme environments.

Novelty and Inventive Step

The inventive concept's novelty lies in the adaptation of therapeutic microvesicles for specific, narrow markets or unique operational environments. The inventive step is the engineering of microvesicles to survive and thrive in extreme environments, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include microvesicles adapted for space exploration, high-altitude environments, or tropical regions. Variations could include different probiotic bacteria strains, microvesicle formulations, or storage containers designed for specific extreme environments.

Potential Commercial Applications and Market

The inventive concept has commercial potential in the fields of disaster relief, high-security operations, and extreme sports. The target market includes government agencies, military organizations, and companies operating in extreme environments.

Field of Art

Microbiology, probiotic bacterial engineering, therapeutic microvesicle development, with expertise in bacterial strain modification and environmental adaptation techniques

Person of Ordinary Skill (PHOSITA) Profile

A microbiologist with advanced degree, experienced in probiotic research, familiar with bacterial strain preservation techniques, microvesicle production methods, and environmental stress response mechanisms

Obviousness Rationale

A PHOSITA would recognize that adapting probiotic microvesicles for extreme environments represents a predictable extension of the source patent's core technology. The fundamental principles of bacterial strain preservation and microvesicle production disclosed in US 11857582 provide a clear technical foundation for environmental adaptation. The variations proposed in the PTD represent routine engineering modifications that would be obvious to a skilled practitioner seeking to expand the utility of probiotic therapeutic microvesicles.

Obvious Combinations & Variations

Source Patent Element
Dried or lyophilized Bifidobacterium longum bacterial strains with therapeutic microvesicle capabilities
PTD Variation
Microvesicles engineered to survive high-temperature and low-oxygen environments
Obviousness Reasoning
Preservation techniques already disclosed suggest predictable modifications for environmental stress resistance using known bacterial engineering techniques
Source Patent Element
Spray-dried and vacuum-dried bacterial strain processing methods
PTD Variation
Specialized storage containers and formulations for extreme environment deployment
Obviousness Reasoning
Existing drying techniques provide a direct technological pathway for creating environment-specific microvesicle preservation methods
Source Patent Element
Bacterial strains capable of inducing microvesicle production
PTD Variation
Targeted microvesicle formulations for specific operational contexts like disaster relief and high-security environments
Obviousness Reasoning
The source patent's fundamental microvesicle production principles enable predictable variations for specialized medical and operational applications
Source Patent Element
Probiotic bacteria for therapeutic microvesicle generation
PTD Variation
Microvesicles adapted for high-altitude and space exploration environments
Obviousness Reasoning
Existing bacterial strain modification techniques provide a clear technological pathway for creating environment-specific microvesicle adaptations
Source Patent Element
Therapeutic microvesicle composition for gut health and immune system function
PTD Variation
Specialized microvesicle formulations targeting specific environmental health challenges
Obviousness Reasoning
The core therapeutic mechanism remains consistent, with variations representing routine design choices within established probiotic engineering principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857582 and the disclosed variations in this published technical disclosure, a person having ordinary skill in the art would find the proposed microvesicle adaptations for extreme environments to be obvious extensions of existing probiotic bacterial engineering techniques. The variations represent predictable modifications that would be apparent to a skilled practitioner seeking to expand the utility of therapeutic microvesicles across diverse operational contexts.

Original Patent Information

Patent NumberUS 11,857,582
TitleTherapeutic microvesicles of probiotic bacteria
Assignee(s)BioGaia AB